Overview of the therapeutic potential of piplartine (piperlongumine)

European Journal of Pharmaceutical Sciences

Volumn 48, Issue 3, 2013, Pages 453-463

  Bezerra, Daniel P ^a   Pessoa, Claudia ^b   De Moraes, Manoel O ^b   Saker Neto, Nicolau ^b   Silveira, Edilberto R ^b   Costa Lotufo, Leticia V ^b  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Anticancer activity; Ayurvedic medicine; Long pepper; Piperaceae; Piperlongumine; Piplartine

Indexed keywords

ALKALOID DERIVATIVE; ANGIOGENESIS INHIBITOR; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTILEISHMANIAL AGENT; ANTIMETASTATIC AGENT; ANTINEOPLASTIC AGENT; ANTINOCICEPTIVE AGENT; ANTITHROMBOCYTIC AGENT; ANTITRYPANOSOMAL AGENT; ANXIOLYTIC AGENT; CARBONYL REDUCTASE; CASPASE 3; CYCLIN B1; CYCLIN D1; FLUOROURACIL; GLUTATHIONE S TRANSFERASE ZETA 1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; HEAT SHOCK PROTEIN 70; NERVE CELL ADHESION MOLECULE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PIPLARTINE; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; NEW DRUG; PIPERIDONE DERIVATIVE;

ANTIANGIOGENIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIDEPRESSANT ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTINOCICEPTION; ANTIPROLIFERATIVE ACTIVITY; BLADDER CARCINOMA; BREAST ADENOCARCINOMA; BREAST CARCINOMA; CANCER INHIBITION; CANCER RESISTANCE; CHROMATIN CONDENSATION; DNA FRAGMENTATION; DRUG BIOAVAILABILITY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; DRUG STRUCTURE; G2 PHASE CELL CYCLE CHECKPOINT; GENOTOXICITY; HUMAN; LUNG CARCINOMA; MAXIMUM PLASMA CONCENTRATION; MELANOMA; METASTASIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SARCOMA; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION INHIBITION; TRANQUILIZING ACTIVITY; ANIMAL; AYURVEDA; BIOAVAILABILITY; CHEMISTRY; FRUIT; METABOLISM; NEOPLASMS; PATENT; PIPER (PLANT);

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL AVAILABILITY; DRUGS, INVESTIGATIONAL; FRUIT; HUMANS; MEDICINE, AYURVEDIC; NEOPLASMS; PATENTS AS TOPIC; PIPER; PIPERIDONES;

EID: 84872410958     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.12.003     Document Type: Review

References (75)

1. Adams, D.J., Dai, M., Pellegrino, G., Wagner, B.K., Stern, A.M., Shamji, A.F., Schreiber, S.L., 2012. Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs. Proc. Natl. Acad. Sci. USA 109 (38), 15115-15120.
2. Atal, C.K., Banga, S.S., 1961. Abstracts of Symposium on Production and Utilization of Medicinal and Aromatic Plants in India. Jammu, India, 23.
3. Atal, C.K., Banga, S.S., 1962. Phytochemical studies on stem of P. longum. Indian J. Pharm. 24, 105.
4. Atal, C.K., Banga, S.S., 1963. Structure of piplartine-a new alkaloid from Piper longum. Curr. Sci. 32, 354-355.
5. Banerjee, T., Chaudhuri, S., 1986. The crystal and molecular structure of N-(3,4,5'"trimethoxycinnamoyl)-D3-piperidine-2-one, an amide alkaloid (piperlongumine), C17H19NO5. Can. J. Chem. 64, 876-880.
6. Banerji, A., Banerji, J., Chatterjee, A., Shoolery, J.N., 1980. Structure and stereochemistry of an alkamide from Piper sylvaticum. Indian J. Chem. 19B, 346-349.
7. Bezerra, D.P., Pessoa, C., Moraes, M.O., Silveira, E.R., Lima, M.A., Elmiro, F.J., Costa-Lotufo, L.V., 2005. Antiproliferative effects of two amides, piperine and piplartine, from Piper species. Z. Naturforsch. C 60 (7-8), 539-543.
8. Bezerra, D.P., Castro, F.O., Alves, A.P., Pessoa, C., Moraes, M.O., Silveira, E.R., Lima, M.A., Elmiro, F.J., Costa-Lotufo, L.V., 2006. In vivo growth-inhibition of Sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper. Braz. J. Med. Biol. Res. 39 (6), 801-807.
9. Bezerra, D.P., Militao, G.C., Castro, F.O., Pessoa, C., Moraes, M.O., Silveira, E.R., Lima, M.A., Elmiro, F.J., Costa-Lotufo, L.V., 2007. Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways. Toxicol. In Vitro 21 (1), 1-8.
10. Bezerra, D.P., Castro, F.O., Alves, A.P., Pessoa, C., Moraes, M.O., Silveira, E.R., Lima, M.A., Elmiro, F.J., Alencar, N.M., Mesquita, R.O., Lima, M.W., Costa-Lotufo, L.V., 2008a. In vitro and in vivo antitumor effect of 5-FU combined with piplartine and piperine. J. Appl. Toxicol. 28 (2), 156-163.
11. Bezerra, D.P., Moura, D.J., Rosa, R.M., Vasconcellos, M.C., Silva, A.C., Moraes, M.O., Silveira, E.R., Lima, M.A., Henriques, J.A., Costa-Lotufo, L.V., Saffi, J., 2008b. Evaluation of the genotoxicity of piplartine, an alkamide of Piper tuberculatum, in yeast and mammalian V79 cells. Mutat. Res. 652 (2), 164-174.
12. Bezerra, D.P., Vasconcellos, M.C., Machado, M.S., Villela, I.V., Rosa, R.M., Moura, D.J., Pessoa, C., Moraes, M.O., Silveira, E.R., Lima, M.A., Aquino, N.C., Henriques, J.A., Saffi, J., Costa-Lotufo, L.V., 2009. Piplartine induces genotoxicity in eukaryotic but not in prokaryotic model systems. Mutat. Res. 677 (1-2), 8-13.
13. Bezerra, D.P., Pessoa, C., Moraes, M.O., Costa-Lotufo, L.V., Gouvea, D.R., Jabor, V.A.P., Lopes, N.P., Borges, K.B., Lima, M.A.S., Silveira, E.R., 2011. Sensitive method for determination of piplartine, an alkaloid amide from Piper species, in rat plasma samples by liquid chromatography-tandem mass spectrometry. Quím. Nova 35 (3), 460-465.
14. Bodiwala, H.S., Singh, G., Singh, R., Dey, C.S., Sharma, S.S., Bhutani, K.K., Singh, I.P., 2007. Antileishmanial amides and lignans from Piper cubeba and Piper retrofractum. J. Nat. Med. 61 (4), 418-421.
15. Bokesch, H.R., Gardella, R.S., Rabe, D.C., Bottaro, D.P., Linehan, W.M., McMahon, J.B., McKee, T.C., 2011. A new hypoxia inducible factor-2 inhibitory pyrrolinone alkaloid from roots and stems of Piper sarmentosum. Chem. Pharm. Bull. 59 (9), 1178-1179.
16. Boll, P.M., Hansen, J., Simonsen, O., Thorup, N., 1984. Synthesis and molecular structure of piplartine (=piperlongumine). Tetrahedron 40 (1), 171-175.
17. Braz-Filho, R., Souza, M.P., Mattos, M.E.O., 1981. Piplartine-dimer A, a new alkaloid from Piper tuberculatum. Phytochemistry 20 (2), 345-346.
18. Chai, P.P.K., Lee, B.M.H., Ismawi, O., 1989. Native Medicinal Plants of Sarawak. Forest Department Sarawak.
19. Chatterjee, A., 1964. IUPAC Abstracts of Symposium on the Chemistry of Natural Products. Kyoto, Japan, 82.
20. Chatterjee, A., Dutta, C.P., 1963. The structure of piperlongumine, a new alkaloid isolated from the roots of Piper longum. Sci. Cult. 29, 568-570.
21. Chatterjee, A., Dutta, C.P., 1967. Alkaloids of Piper longum Linn. I. Structure and synthesis of piperlongumine and piperlonguminine. Tetrahedron 23 (4), 1769-1781.
22. Chaudhary, M.R., Chandrasekaran, R., Mishra, S., 2001. Embryotoxicity and teratogenicity studies of an Ayurvedic contraceptive-pippaliyadi vati. J. Ethnopharmacol. 74 (2), 189-193.
23. Chopra, R.N., Nayar, S.L., Chopra, I.C., 1956. In: Glossary of Indian Medicinal Plants, first ed. National institute of science and communication, New Delhi, 111-115.
24. Costa-Lotufo, L.V., Montenegro, R.C., Alves, A.P.N.N., Madeira, S.V.F., Pessoa, C., Moraes, M.E.A., Moraes, M.O., 2010. The contribution of natural products as source of new anticancer drugs: Studies carried out at the national experimental oncology laboratory from the Federal University of Ceará. Ver. Virtual Quím. 2 (1), 47-58.
25. Cotinguiba, F., Regasini, L.O., Bolzani, V.S., Debonsi, H.M., Passerini, G.D., Cicarelli, R.M.B., Kato, M.J., Furlan, M., 2009. Piperamides and their derivatives as potential anti-trypanosomal agents. Med. Chem. Res. 18 (9), 703-711.
26. Dodson, C.D., Dyer, L.A., Searcy, J., Wrigh, Z., Letourneau, D.K., 2000. Cenocladamide, a dihydropyridone alkaloid from Piper cenocladum. Phytochemistry 53 (1), 51-54.
27. Duh, C.Y., Wu, Y.C., Wang, S.K., 1990a. Cytotoxic pyridone alkaloids from the leaves of Piper aborescens. J. Nat. Prod. 53 (6), 1575-1577.
28. Duh, C.Y., Wu, Y.C., Wang, S.K., 1990b. Cytotoxic pyridone alkaloids from Piper aborescens. Phytochemistry 29 (8), 2689-2691.
29. Facundo, V.A., Silveira, A.S.P., Morais, S.M., 2005. Constituents of Piper alatabaccum Trel & Yuncker (Piperaceae). Biochem. Syst. Ecol. 33 (7), 753-756.
30. Felipe, F.C.B., Sousa-Filho, J.T., Souza, L.E.O., Silveira, J.A., Uchoa, D.E.A., Silveira, E.R., Pessoa, O.D.L., Viana, G.S.B., 2007. Piplartine, an amide alkaloid from Piper tuberculatum, presents anxiolytic and antidepressant effects in mice. Phytomedicine 14 (9), 605-612.
31. Fontenele, J.B., Leal, L.K., Silveira, E.R., Felix, F.H., Felipe, F.C.B., Viana, G.S., 2009. Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: Possible involvement of cyclooxygenase blockade and antioxidant activity. J. Pharm. Pharmacol. 61 (4), 511-515.
32. Golovine, K.V., Makhov, P.B., Teper, E., Kutikov, A., Canter, D., Uzzo, R.G., Kolenko, V.M., 2013. Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells. Prostate 73 (1), 23-30.
33. Iwashita, M., Oka, N., Ohkubo, S., Saito, M., Nakahata, N., 2007. Piperlongumine, a constituent of Piper longum L., inhibits rabbit platelet aggregation as a thromboxane A(2) receptor antagonist. Eur. J. Pharmacol. 570 (1-3), 38-42.
34. Joshi, B.S., Kamat, V.N., Saksena, A.K., 1968. The structure of piplartine and a synthesis of dihydropiplartine. Tetrahedron Lett. 9 (20), 2395-2400.
35. Jyothi, D., Vanathi, P., Gowri, P.M., Rao, V.R.S., Rao, J.M., Sreedhar, A.S., 2009. Diferuloylmethane augments the cytotoxic effects of piplartine isolated from Piper chaba. Toxicol. In Vitro 23 (6), 1085-1091.
36. Kirtikar, K.R., Basu, B.D., 1980. Indian medicinal plants. In: Singh, B., Singh, M.P., vol. 1, second ed., India.
37. Kong, E.H., Kim, Y.J., Kim, Y.J., Cho, H.J., Yu, S.N., Kim, K.Y., Chang, J.H., Ahn, S.C., 2008. Piplartine induces caspase-mediated apoptosis in PC-3 human prostate cancer cells. Oncol. Rep. 20 (4), 785-792.
38. Kumar, S., Kamboj, J.Suman., Sharma, S., 2011. Overview for various aspects of the health benefits of Piper longum linn. Fruit. J. Acupunct. Meridian Stud. 4 (2), 134-140.
39. Lee, S.W., Mandinova, A., 2009. Patent application title: Methods for the treatment of cancer using piperlongumine and piperlongumine Analogs. WO 20090312373.
40. Lee, S.E., Park, B.S., Kim, M.K., Choi, W.S., Kim, H.T., Cho, K.Y., Lee, S.G., Lee, H.S., 2001. Fungicidal activity of pipernonaline, a piperidine alkaloid derived from long pepper, Piper longum L., against phytopathogenic fungi. Crop Prot. 20 (6), 523-528.
41. Lee, S.E., Mahoney, N.E., Campbell, B.C., 2002. Inhibition of aflatoxin B1 biosynthesis by piperlongumine isolated from Piper longum L. J. Microbiol. Biotechnol. 12 (4), 679-682.
42. Lee, S.E., Park, B.S., Bayman, P., Baker, J.L., Choi, W.S., Campbell, B.C., 2007. Suppression of ochratoxin biosynthesis by naturally occurring alkaloids. Food Addit. Contam. 24 (4), 391-397.
43. Lee, S.E., Park, B.S., Huh, T.L., Lee, E.W., Yum, J.H., 2010. Proteomic evaluation on antiplatelet activity of piperlongumine derived from Piper longum. Mol. Cell. Toxicol. 6 (3), 295-303.
44. Lin, Z., Liao, Y., Venkatasamy, R., Hider, R.C., Soumyanath, A., 2007. Amides from Piper nigrum L. with dissimilar effects on melanocyte proliferation in vitro. J. Pharm. Pharmacol. 59 (4), 529-536.
45. Lokhande, P.D., Gawai, K.R., Kodam, K.M., Kuchekar, B.S., Chabukswar, A.R., Jagdale, S.C., 2007. Antibacterial activity of extracts of Piper longum. J. Pharmacol. Toxicol. 2 (6), 574-579.
46. Mishra, S.S., Tewari, J.P., 1964. Phytochemical investigation of Piper chaba. J. Pharm. Sci. 53 (11), 1423-1424.
47. Moraes, J., Nascimento, C., Lopes, P.O., Nakano, E., Yamaguchi, L.F., Kato, M.J., Kawano, T., 2011. Schistosoma mansoni: In vitro schistosomicidal activity of piplartine. Exp. Parasitol. 127 (2), 357-364.
48. Moraes, J., Nascimento, C., Yamaguchi, L.F., Kato, M.J., Nakano, E., 2012a. Schistosoma mansoni: In vitro schistosomicidal activity and tegumental alterations induced by piplartine on schistosomula. Exp. Parasitol. 132 (2), 222-227.
49. Moraes, J., Keiser, J., Ingram, K., Nascimento, C., Yamaguchi, L.F., Bittencourt, C.R., Bemquerer, M.P., Leite, J.R., Kato, M.J., Nakano, E., In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Schistosoma mansoni schistosomula and adult worms. Curr. Med. Chem. in press.
50. Morandim-Gianetti, A.A., Cotinguiba, F., Regasini, L.O., Frigieri, M.C., Varanda, E.A., Coqueiro, A., Kato, M.J., Bolzani, V.S., Furlan, M., 2011. Study of Salmonella typhimurium mutagenicity assay of (E)-piplartine by the Ames test. Afr. J. Biotechnol. 10 (27), 5398-5401.
51. Naika, R., Prasanna, K.P., Ganapathy, P.S.S., 2010. Antibacterial activity of piperlongumine an alkaloid isolated from methanolic root extract of Piper Longum L. Pharmacophore 1 (2), 141-148.
52. Narayanan, S., 1993. Aldose reductase and its inhibition in the control of diabetic complications. Ann. Clin. Lab. Sci. 23 (2), 148-158.
53. Navickiene, H.M., Alecio, A.C., Kato, M.J., Bolzani, V.D., Young, M.C., Cavalheiro, A.J., Furlan, M., 2000. Antifungal amides from Piper hispidum and Piper tuberculatum. Phytochemistry 55 (6), 621-626.
54. Navickiene, H.M., Bolzani, V.S., Kato, M.J., Pereira, A.M.S., Bertoni, B.W., França, S.C., Furlan, Maysa., 2003. Quantitative determination of anti-fungal and insecticide amides in adult plants, plantlets and callus from Piper tuberculatum by reversephase high-performance liquid chromatography. Phytochem. Anal. 14 (5), 281-284.
55. Palacios, Z.G.F., Delgado, G.E., Moreno, M.C., Kato, M.J., Rojas, C., 2009. Actividad antifúngica in vitro de extractos crudos de Piper tuberculatum. Rev. Peru. Biol. 16 (2), 209-214.
56. Park, B.S., Son, D.J., Park, Y.H., Kim, T.W., Lee, S.E., 2007. Antiplatelet effects of acidamides isolated from the fruits of Piper longum L. Phytomedicine 14 (12), 853-855.
57. Park, B.S., Son, D.J., Choi, W.S., Takeoka, G.R., Han, S.O., Kim, T.W., Lee, S.E., 2008. Antiplatelet activities of newly synthesized derivatives of piperlongumine. Phytother. Res. 22 (9), 1195-1199.
58. Parkinson, E.I., Hergenrother, P.J., 2011. Runaway ROS as a selective anticancer strategy. ChemMedChem 6 (11), 1957-1959.
59. Parmar, V.S., Jain, S.C., Bisht, K.S., Jain, R., Taneja, P., Jha, A., Tyagi, O.D., Prasad, A.K., Wengel, J., Olesen, C.E., Boll, P.M., 1997. Phytochemistry of the Genus Piper. Phytochemistry 46 (4), 597-673.
60. Prabhu, B.R., Mulchandani, N.B., 1985. Biosynthesis of piperlongumine. Phytochemistry 24 (11), 2589-2592.
61. Raj, L., Ide, T., Gurkar, A.U., Foley, M., Schenone, M., Li, X., Tolliday, N.J., Golub, T.R., Carr, S.A., Shamji, A.F., Stern, A.M., Mandinova, A., Schreiber, S.L., Lee, S.W., 2011. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475 (7355), 231-234.
62. Rao, V.R., Muthenna, P., Shankaraiah, G., Akileshwari, C., Babu, K.H., Suresh, G., Babu, K.S., Kumar, R.S.C., Prasad, K.R., Yadav, P.A., Petrash, J.M., Reddy, G.B., Rao, J.M., 2012. Synthesis and biological evaluation of new piplartine analogues as potent aldose reductase inhibitors (ARIs). Eur. J. Med. Chem. 57C, 344-361.
63. Ribeiro, J.E.L.S., Hopkins, M.J.G., Vicentin, A., Sothers, C.A., Costa, M.A.S., Brito, J.M., Souza, M.A.D., Martins, L.H.P., Lohmann, L.G., Assunçao, P.A.C.L., Pereira, E.C., Mesquita, M.R., Procópio, L.C., 1999. Flora da Reserva Ducke-Guia de identificaçao das plantas vasculares de uma floresta de terra-firme na Amazônia Central. INPA-DFID, Manaus, Amazonas, Brazil, 181-187.
64. Riccioni, G., De Santis, A., Cerasa, V., Menna, V., Di Ilio, C., Schiavone, C., Ballone, E., D'Orazio, N., 2003. Atherosclerotic plaque formation and risk factors. Int. J. Immunopathol. Pharmacol. 16 (1), 25-31.
65. Rodrigues, R.V., Lanznaster, D., Balbinot, D.T.L., Gadotti, V.M., Facundo, V.A., Santos, A.R., 2009. Antinociceptive effect of crude extract, fractions and three alkaloids obtained from fruits of Piper tuberculatum. Biol. Pharm. Bull. 32 (10), 1809-1812.
66. Schaab, E.H., Crotti, A.E., Iamamoto, Y., Kato, M.J., Lotufo, L.V., Lopes, N.P., 2010. Biomimetic oxidation of piperine and piplartine catalyzed by iron(III) and manganese(III) porphyrins. Biol. Pharm. Bull. 33 (5), 912-916.
67. Silva, R.V., Navickiene, H.M., Kato, M.J., Bolzani, V.D.A.S., Meda, C.I., Young, M.C., Furlan, M., 2002. Antifungal amides from Piper arboreum and Piper tuberculatum. Phytochemistry 59 (5), 521-527.
68. Son, D.J., Kim, S.Y., Han, S.S., Kim, C.W., Kumar, S., Park, B.S., Lee, S.E., Yun, Y.P., Jo, H., Park, Y.H., 2012. Piperlongumine inhibits atherosclerotic plaque formation and vascular smooth muscle cell proliferation by suppressing PDGF receptor signaling. Biochem. Biophys. Res. Commun. 427 (2), 349-354.
69. Srivastava, R.C., Adi Community, 2009. Traditional knowledge of Adi tribe of Arunachal Pradesh on plants. Indian J. Trad. Knowl. 8 (2), 146-153.
70. Tsai, I.L., Lee, F.P., Wu, C.C., Duh, C.Y., Ishikawa, T., Chen, J.J., Chen, Y.C., Seki, H., Chen, I.S., 2005. New cytotoxic cyclobutanoid amides, a new furanoid lignan and antiplatelet aggregation constituents from Piper arborescens. Planta Med. 71 (6), 535-542.
71. Wu, Q.L., Wang, S.P., Tu, G.Z., Feng, Y.X., Yang, J.S., 1997. Alkaloids from Piper puberullum. Phytochemistry 44 (4), 727-730.
72. Yang, Y.C., Lee, S.G., Lee, H.K., Kim, M.K., Lee, S.H., Lee, H.S., 2002. A piperidine amide extracted from Piper longum L. fruit shows activity against Aedes aegypti mosquito larvae. J. Agric. Food Chem. 50 (13), 3765-3767.
73. Yusuf, M., Chowdhury, J.U., Wahab, M.A., Begum, J., 1994. Medicinal Plants of Bangladesh BCSIR. Dhaka, Bangladesh, 193.
74. Zhang, P., Huang, Q.-I., Hua, Z.-C., 2012. Advances in studies on pharmacological effects of piperlongumine. Chinese Tradit. Herbal Drugs 43 (1), 201-204.
75. Zhou, J., Xie, G., Yan, X., 2011. Encyclopedia of Traditional Chinese Medicines: Molecular Structures, Pharmacological Activities, Natural Sources and Applications. Springer Verlag, 3934.